Research programme: G protein-coupled receptor - targeting antibody-drug conjugates - LegoChem Bioscience/Theranyx

Drug Profile

Research programme: G protein-coupled receptor - targeting antibody-drug conjugates - LegoChem Bioscience/Theranyx

Alternative Names: LCB14-XXXX - LegoChem Bioscience/Theranyx

Latest Information Update: 08 Mar 2017

Price : $50

At a glance

  • Originator LegoChem Biosciences; Theranyx
  • Class Antibodies; Antineoplastics; Drug conjugates
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Cancer

Most Recent Events

  • 01 Dec 2015 Early research in Cancer in France (Parenteral)
  • 01 Dec 2015 Early research in Cancer in South Korea (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top